In intermediate risk prostate cancer patients randomized to short-term ADT and either 70 Gy or 76 Gy, testosterone recovery ...
The presence of adverse molecular features most closely correlated with genomic classifier scores, even within low grade tumors. There was an observed nearly 20-fold increase in the presence of ...
(UroToday.com) The 2025 ASTRO annual meeting featured a predictive markers in prostate cancer session and a presentation by Dr. Melvin L. K. Chua discussing validation of a prognostic multimodal ...
Primary physician reporting grade 2+ toxicity per CTCAE version 5.0 was the primary endpoint. Follow-up was performed 30 days post-treatment and subsequently every 3 to 4 months for 2 years: ...
Analysis of Genomic Drivers of Discordant Risk Classifications in Prostate Cancer - Michael Zelefsky
Michael Zelefsky shares extensive genomic profiling analysis with Daniel Spratt, examining over 200,000 prostate biopsies to illuminate discordances between traditional NCCN risk groups and Decipher ...
Perspectives on the Urological Care in Parkinson’s Disease Patients - Beyond the Abstract ...
The association between prior pelvic radiotherapy for cancer and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: An analysis of national surgical quality improvement ...
E David Crawford interviews Jason Efstathiou about the PARTIQoL trial, a Phase III study comparing proton beam therapy to IMRT for localized prostate cancer. Dr. Efstathiou presents the study's design ...
An external urine collection device (EUCD) is defined as a catheter or product that attaches to the perineum. These collection systems drain urine via tubing attached to a bag or via tubing that ...
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas was host to the Abstract/Posters Session. Dr Joaquim Bellmunt presented the disease-free survival and overall ...
Phase 2 EXTEND Trial of Metastasis-Directed Therapy with Continuous Hormone Therapy - Alexander Sherry & Bilal Siddiqui Validating the APUC-6 Signature in mHSPC from the ECOG-ACRIN E3805 CHAARTED ...
Mismatch repair deficiency (dMMR), microsatellite instability (MSI-H), and high tumor mutational burden (TMB-H) have emerged as clinically important biomarkers in prostate cancer with direct ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback